Electrosmog and Dementia

1 June 2012

Here are references and links to 72 articles linking electrosmog exposures with dementia. The current ICNIRP’s safety guidelines for radiofrequency exposures were only developed to protect healthy adult males under 6 minute exposures. How much evidence is needed to apply the precautionary principle? For other EMF bibliographies see: http://www.scribd.com/collections/3440803/Electrosmog-Bibiographies


Andel R, Crowe M, Feychting M, Pedersen NL, Fratiglioni L, Johansson B, Gatz M. (2010). Work-related exposure to extremely low-frequency magnetic fields and dementia: results from the population-based study of dementia in Swedish twins. J Gerontol A Biol Sci Med Sci. 65(11):1220-7. http://www.ncbi.nlm.nih.gov/pubmed/20622138 Arendash GW., J. Sanchez-Ramosc, T. Morie, M. Mamcarz, X. Linc, M. Runfeldt, L.Wang, G. Zhang,V. Savad, J.Tang, C. Cao. (2010). Electromagnetic field treatment protects against and reverses cognitive impairment in Alzheimer’s disease mice. J. Alzheimer’s Dis. 19: 191–210. http://www.ncbi.nlm.nih.gov/pubmed/20061638 Bobkova NV, VV Novikov, NI Medvinskaya, IY Aleksandrova, IV Nesterova, EE Fesenko (2010). The weak combined magnetic fields induce the reduction of brain amyloid-β level in two animal models of Alzheimer’s disease. IN: Non-Thermal Effects and Mechanisms of Interaction Between Electromagnetic Fields and Living Matter. Giuliani, L. and M. Soffritti (Eds). 2010. An ICEMS Monograph, Ramazzini Institute. Eur. J. Oncol. Library 5: 235-46. http://www.icems.eu/papers.htm Chang Q, He Y, Ni B, Feng K, Jiang Y, Jiang B. (2004). [A case-control study on the risk factors of Alzheimer's disease in military elderly men]. Zhonghua Liu Xing Bing Xue Za Zhi. 25(10):890-3. [Article in Chinese]. http://www.ncbi.nlm.nih.gov/pubmed/15631750 Davanipour Z, Tseng CC, Lee PJ, Sobel E. (2007). A case-control study of occupational magnetic field exposure and Alzheimer's disease: results from the California Alzheimer's Disease Diagnosis and Treatment Centers. BMC Neurol. 9: 7:13. http://www.ncbi.nlm.nih.gov/pubmed/17559686 Davanipour, Z., Sobel, E. (2009). Long-term exposure to magnetic fields and the risks of Alzheimer's disease and breast cancer: Further biological research. Pathophysiology. 16(2-3):149-56. http://www.journals.elsevierhealth.com/periodicals/patphy/issues/contents?issue_key=S0928-4680(09)X00039: Davies DC, Hardy JA (1988). Blood brain barrier in ageing and Alzheimer's disease. Neurobiol Aging. 9(1):468 http://www.ncbi.nlm.nih.gov/pubmed/3380253 Dragicevic N, Bradshaw PC, Mamcarz M, Lin X, Wang L, Cao C, Arendash GW. (2011). Long-term electromagnetic field treatment enhances brain mitochondrial function of both Alzheimer's transgenic mice and normal mice: a mechanism for electromagnetic field-induced cognitive benefit? Neuroscience. 185:135-49 http://www.ncbi.nlm.nih.gov/pubmed/21514369 Feychting M, Jonsson F, Pedersen NL, Ahlbom A. (2003). Occupational magnetic field exposure and neurodegenerative disease. Epidemiology. 14:413–419. http://www.ncbi.nlm.nih.gov/pubmed/12843764 Feychting M, Pedersen NL, Svedberg P, et al. (1998). Dementia and occupational exposure to magnetic fields. Scand J Work Environ Health; 24: 46–53. http://www.ncbi.nlm.nih.gov/pubmed/9562400 Francis PT. (2005). The interplay of neurotransmitters in Alzheimer’s disease. CNS Spectrums. 10(11):6–9. http://www.ncbi.nlm.nih.gov/pubmed/16273023 García A, Sisternas A, Hoyos S (2008). Occupational exposure to extremely low frequency electric and magnetic fields and Alzheimer disease: a meta-analysis. Int J Epidemiol 37, 329-340. http://www.ncbi.nlm.nih.gov/pubmed/18245151 Håkansson N, Gustavsson P, Johansen C, Floderus B. (2003). Neurodegenerative disease in welders and other workers exposed to high levels of magnetic fields. Epidemiology 14:420-426. http://www.ncbi.nlm.nih.gov/pubmed/12843765 Hallberg Ö, Johansson O. (2005). Alzheimer mortality—why does it increase so fast in sparsely populated areas? Eur. Biol. Bioelectromag. 1:225–246. -1-






7. 8.

9. 10. 11. 12.



Electrosmog and Dementia

1 June 2012

http://www.buergerwelle.de/pdf/martin_weatherall/brain_development/alzheimer_mortality_in_sparsley_popul ated_areas.pdf

15. 16. 17.

Hallberg O. (2009). Is Increased Mortality from Alzheimer’s Disease in Sweden a Reflection of Better Diagnostics? Current Alzheimer Research 6: 471-475. http://www.bentham.org/car/samples/car6-6/002AT.pdf Harik SI, Kalaria RN (1991). Blood-brain barrier abnormalities in Alzheimer's disease. Ann N Y Acad Sci;;640:47-52 http://www.ncbi.nlm.nih.gov/pubmed/1685645 Harmanci H; Emre, M; Gurvit, H; Bilgic, B Hanagasi, H; Gurol, E; Sahin, H; Tinaz, S (2003). Risk Factors for Alzheimer Disease: A Population-Based Case-Control Study in Istanbul, Turkey. Alzheimer Disease & Associated Disorders 17(3); 139-145. http://www.ncbi.nlm.nih.gov/pubmed/14512826 Holder, J, Warren, AC. (1998). Prevalence of Alzheimer's Disease and Apolipoprotein E Allele Frequencies in the Old Order Amish. The Journal of Neuropsychiatry and Clinical Neurosciences. 10:100-102. http://neuro.psychiatryonline.org/article.aspx?Volume=10&page=100&journalID=62 Hug K, Röösli M, Rapp R. (2006). Magnetic field exposure and neurodegenerative diseases--recent epidemiological studies. Soz Praventivmed.51(4):210-20. http://www.ncbi.nlm.nih.gov/pubmed/17193783 Huss A, Spoerri A, Egger M et al. (2009) Residence near power lines and mortality from neurodegenerative diseases: longitudinal study of the Swiss population Am J Epidemiol 169(2):167-75 http://www.ncbi.nlm.nih.gov/pubmed/18990717 Kalaria RN. (1999). The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease. Ann N Y Acad Sci. 893:113-25. http://www.ncbi.nlm.nih.gov/pubmed/10672233 r.n.kalaria@ncl.ac.uk Li G, Shen YC, Li YT, et al. (1992). A case-control study of Alzheimer’s disease in China. Neurology. 42:1481–8. http://www.ncbi.nlm.nih.gov/pubmed/1641140 Mattila KM, Pirttilä T, Blennow K, Wallin A, Viitanen M, Frey H (1994). Altered blood-brain-barrier function in Alzheimer's disease? Acta Neurol Scand; 89(3):192-8 http://www.ncbi.nlm.nih.gov/pubmed/8030400 Mooradian AD: Effect of aging on the blood-brain barrier. Neurobiol Aging; 1988 Jan-Feb;9(1):31-9 http://www.ncbi.nlm.nih.gov/pubmed/3288893 Noonan CW, Reif JS, Yost M, et al. (2002). Occupational exposure to magnetic fields in case-referent studies of neurodegenerative diseases. Scand J Work Environ Health; 28:42–8. http://www.ncbi.nlm.nih.gov/pubmed/11871851 Olcese J, Cao C, Mori T, Mamcarz M, Maxwell A, Runfeldt M, Wang L, Zhang C, Lin X, Zhang G, Arendash G (2009). Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. J Pineal Res 47: 82-96. http://www.ncbi.nlm.nih.gov/pubmed/19538338 Park RM, Schulte PA, Bowman JD, Walker JT, Bondy SC, Yost MG, Touchstone JA, Dosemeci M: (2005). Potential occupational risks for neurodegenerative diseases. Am J Ind Med 48:63-77. http://www.ncbi.nlm.nih.gov/pubmed?term=15940722 Popescu BO, Toescu EC, Popescu LM, Bajenaru O, Muresanu DF, Schultzberg M, Bogdanovic N (2009). Blood-brain barrier alterations in ageing and dementia. J Neurol Sci; 283(1-2):99-106 http://www.ncbi.nlm.nih.gov/pubmed/19264328 Qiu C, Fratiglioni L, Karp A, Winblad B, Bellander T. (2004). Occupational exposure to electromagnetic fields and risk of Alzheimer's disease. Epidemiology.15(6):687-94. http://www.ncbi.nlm.nih.gov/pubmed/15475717 Röösli M, Lörtscher M, Egger M, Pfluger D, Schreier N, Lörtscher E, Locher P, Spoerri A, Minder C. (2007). Mortality from neurodegenerative disease and exposure to extremely low-frequency magnetic fields: 31 years of observations on Swiss railway employees. Neuroepidemiology. 28(4):197-206. http://www.ncbi.nlm.nih.gov/pubmed?term=17851258 Sandyk R. (1994). A drug naive parkinsonian patient successfully treated with weak electromagnetic fields. Int J Neurosci. .79 (1-2):99-110. http://www.ncbi.nlm.nih.gov/pubmed/7744555


19. 20.

21. 22. 23. 24. 25.





57. 58.



Electrosmog and Dementia

1 June 2012

Santibáñez M, F Bolumar, and AM García. (2007). Occupational risk factors in Alzheimer's disease: a review assessing the quality of published epidemiological studies. Occup Environ Med. 64(11): 723–32. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2078415/pdf/723.pdf Savitz DA, Checkoway H, Loomis DP (1998): Magnetic field exposure and neurodegenerative disease mortality among electric utility workers. Epidemiology 9:398-404. http://www.ncbi.nlm.nih.gov/pubmed/9647903 Savitz DA, Loomis DP, Tse CK. (1998). Electrical occupations and neurodegenerative disease: analysis of U.S. mortality data. Arch Environ Health 53:71–4. http://www.ncbi.nlm.nih.gov/pubmed/9647903 Schulte PA, Burnett CA. (1997). EMFs and Alzheimer’s disease. Neurology. 49:312–313. http://www.ncbi.nlm.nih.gov/pubmed/9222224 Schüz J, Waldemar G, Olsen JH, Johansen C. (2009). Risks for central nervous system diseases among mobile phone subscribers: a Danish retrospective cohort study. PLoS One. 4(2): e4389. http://www.ncbi.nlm.nih.gov/pubmed/19194493 Shah GN, Mooradian AD. (1997). Age-related changes in the blood-brain barrier. Exp Gerontol. 32(4-5):50119. http://www.ncbi.nlm.nih.gov/pubmed/9315452 Sobel E, Davanipour Z, Sulkava R, et al. (1995). Occupations with exposure to electromagnetic fields: a possible risk factor for Alzheimer’s disease. Am J Epidemio 142:515–24 Sobel E, Dunn M, Davanipour Z, Qian Z, Chui HC (1996). Elevated risk of Alzheimer's disease among workers with likely electromagnetic field exposure. Neurology 47:1477-81. http://www.neurology.org/content/47/6/1477.full.pdf+html Söderqvist F, Hardell L, Carlberg M, Mild, K. (2010). Radiofrequency fields, transthyretin, and Alzheimer's disease. J Alzheimers Dis. 20(2):599-606. http://www.ncbi.nlm.nih.gov/pubmed/20164553 Srinivasan V, Spence DW, Pandi-Perumal SR, Brown GM, Cardinali DP. (2011). Melatonin in mitochondrial dysfunction and related disorders. Int J Alzheimers Dis 326320. Epub 2011 May 4. http://www.ncbi.nlm.nih.gov/pubmed/21629741 Vinters HV, Pardridge WM. (1986). The blood-brain barrier in Alzheimer's disease. Can J Neurol Sci. 13(4 Suppl):446-8. http://www.ncbi.nlm.nih.gov/pubmed/2947668 Wu YH, Swaab DF (2005). The human pineal gland and melatonin in aging and Alzheimer's disease. Journal of pineal research 38(3):145-52. http://www.ncbi.nlm.nih.gov/pubmed?term=15725334 Zlokovic BV. (1998). Alzheimers abeta, apolipoproteins &blood-brain barrier. NIH RePORTER; 07 01 http://projectreporter.nih.gov/project_info_description.cfm?aid=2735675 The Electrosmog Bibliography Collection also contains: Autism (10 References) Blood Brain Barrier (47 References) Breast Cancer (77 References) Cataracts (61 References) Hearing (39 References) Headaches (48 References) Base Stations, TV and radio masts, Power lines (92 References) Depression and suicide (48 References) Male fertility (135 References) Prenatal Effects (166 References) Wildlife (149 References) Other EMF-related Scribd collections which may be of interest include:


62. 63. 64.

65. 66. 67.

68. 69.

70. 71. 72.


Electrosmog and Dementia
http://www.scribd.com/my_document_collections/3228470 (Conflict of interest in science) http://www.scribd.com/my_document_collections/3228507 (Electrosmog and wildlife) http://www.scribd.com/my_document_collections/3222035 (Electrosensitivity) http://www.scribd.com/my_document_collections/3221670 (Electrosmog and male fertility) http://www.scribd.com/my_document_collections/3222195 (The precautionary principle) http://www.scribd.com/my_document_collections/3220833 (EMF-related health risks)

1 June 2012


Sign up to vote on this title
UsefulNot useful